Study of Oral Ceritinib in Patients With ALK and ROS1 Activated Gastrointestinal Malignancies
Clinical trial NCT02638909 · TERMINATED
Trial details
- NCT number
- NCT02638909
- Sponsor
- Criterium, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2018-03-29
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.